Novartis’s Ligelizumab Founders In Phase III Despite Positive Predictions

Fails To Top Xolair in CSU trials

 
• By Ayisha Sharma
  
CSU Causes Itchy, Painful Hives And Angioedema • Source: Alamy

More from Clinical Trials

More from R&D